DOI 10.1080/10428194.2026.2666843
Predictors of acute kidney injury following the first cycle of high-dose methotrexate in patients with hematological malignancies.
Аннотация
Consensus regarding predictors of acute kidney injury (AKI) following high-dose methotrexate (HDMTX) across diverse patient populations remains inconsistent. We conducted a retrospective study to identify predictors of AKI in adult patients with hematological malignancies receiving the first cycle of HDMTX between January 2020 and December 2024. The medical records were reviewed, and cases of AKI were defined, according to Kidney Disease Improving Global Outcomes (KDIGO) criteria. A total of 281 patients were included (Median age 44 years (range 18-82)), of whom 76 (27.0%) developed AKI, with 84.2% having stage I, and 90.8% achieved resolution. The multivariate logistic regression analysis identified hypoalbuminemia (odds ratio (OR) 1.90, p = 0.034), methotrexate concentration ≥ 10 µmol/L at 24 h (OR 2.24, p = 0.013), and lower phosphorus level (OR 1.44, p = 0.043) as independent predictors of AKI. This study helps to identify patients at higher risk of AKI to provide tailored preventive measures.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.